Posted in | News | Materials Analysis

Analytik Jena Closes Acquisition of Bruker's ICP-MS Business and Begins Integration Process

Analytik Jena AG, a manufacturer of analytical measuring technology and life science instruments today announced that it has closed the acquisition of the ICP-MS business of Bruker Corporation (NASDAQ: BRKR) on September 12, 2014. The integration process has begun, and it is scheduled to be completed by the end of 2014.

I am glad that we were able to make this acquisition a reality so quickly and on a fair basis together with Bruker.  The transaction is of great strategic importance for Analytik Jena AG. Now the emphasis will be on integrating the team of employees from Bruker and the assets quickly and smoothly into our organization.

Klaus Berka, Chief Executive Officer of Analytik Jena AG

The ICP-MS business is set to be integrated, along with the products and technologies, patents, licensing rights, and research and development capacities acquired with it, as well as the former Bruker ICP-MS customer service business, into the Analytical Instrumentation business unit at Analytik Jena AG.  Many ICP-MS employees around the world in sales, applications, service, research and development, including the ICP-MS chief developer, have accepted employment at Analytik Jena, or are expected to join Analytik Jena soon.

The established ICP-MS products and technology of Bruker, and previously Varian Inc., has a very good reputation in the market.  That attests to the expertise and dedication of the employees working in this business, as well as to the quality of their work.  We want to expand on the existing potential and grow the ICP-MS business together with the new international team.

Torsten Olschewski, General Manager of the Analytical Instrumentation business unit at Analytik Jena AG

With the acquisition of the ICP-MS business from Bruker, Analytik Jena can now offer its customers the entire portfolio of elemental trace spectrometry. This moves the Company one step closer to its three major competitors. Analytik Jena will present its new technology for the first time at a leading industrial exhibition in China, Analytica China, which will be held in Shanghai from September 24-29, 2014.  In addition, Analytik Jena and its new ICP-MS Chief Developer will present at the SCIX 2014, the summit of the Federation of Analytical Chemistry and Spectroscopy Societies (FACSS) in Reno, Nevada in October.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Analytik Jena US. (2024, March 12). Analytik Jena Closes Acquisition of Bruker's ICP-MS Business and Begins Integration Process. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=42389.

  • MLA

    Analytik Jena US. "Analytik Jena Closes Acquisition of Bruker's ICP-MS Business and Begins Integration Process". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=42389>.

  • Chicago

    Analytik Jena US. "Analytik Jena Closes Acquisition of Bruker's ICP-MS Business and Begins Integration Process". AZoM. https://www.azom.com/news.aspx?newsID=42389. (accessed November 21, 2024).

  • Harvard

    Analytik Jena US. 2024. Analytik Jena Closes Acquisition of Bruker's ICP-MS Business and Begins Integration Process. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=42389.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.